Literature DB >> 28671504

Reliability and validity of a self-administered tool for online neuropsychological testing: The Amsterdam Cognition Scan.

Heleen E M Feenstra1, Jaap M J Murre2, Ivar E Vermeulen3, Jacobien M Kieffer1, Sanne B Schagen1,2.   

Abstract

INTRODUCTION: To facilitate large-scale assessment of a variety of cognitive abilities in clinical studies, we developed a self-administered online neuropsychological test battery: the Amsterdam Cognition Scan (ACS). The current studies evaluate in a group of adult cancer patients: test-retest reliability of the ACS and the influence of test setting (home or hospital), and the relationship between our online and a traditional test battery (concurrent validity).
METHOD: Test-retest reliability was studied in 96 cancer patients (57 female; Mage = 51.8 years) who completed the ACS twice. Intraclass correlation coefficients (ICCs) were used to assess consistency over time. The test setting was counterbalanced between home and hospital; influence on test performance was assessed by repeated measures analyses of variance. Concurrent validity was studied in 201 cancer patients (112 female; Mage = 53.5 years) who completed both the online and an equivalent traditional neuropsychological test battery. Spearman or Pearson correlations were used to assess consistency between online and traditional tests.
RESULTS: ICCs of the online tests ranged from .29 to .76, with an ICC of .78 for the ACS total score. These correlations are generally comparable with the test-retest correlations of the traditional tests as reported in the literature. Correlating online and traditional test scores, we observed medium to large concurrent validity (r/ρ = .42 to .70; total score r = .78), except for a visuospatial memory test (ρ = .36). Correlations were affected-as expected-by design differences between online tests and their offline counterparts.
CONCLUSIONS: Although development and optimization of the ACS is an ongoing process, and reliability can be optimized for several tests, our results indicate that it is a highly usable tool to obtain (online) measures of various cognitive abilities. The ACS is expected to facilitate efficient gathering of data on cognitive functioning in the near future.

Entities:  

Keywords:  Amsterdam Cognition Scan; computer skills; concurrent validity; intraclass correlation coefficient; neuropsychological test battery; oncology; test development; test–retest reliability; unmonitored setting

Mesh:

Year:  2017        PMID: 28671504     DOI: 10.1080/13803395.2017.1339017

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  20 in total

1.  Novel computerized neurocognitive test battery is sensitive to cancer-related cognitive deficits in survivors.

Authors:  Alexandra M Gaynor; Anam Ahsan; Duane Jung; Elizabeth Schofield; Yuelin Li; Elizabeth Ryan; Tim A Ahles; James C Root
Journal:  J Cancer Surviv       Date:  2022-08-08       Impact factor: 4.062

2.  Augmenting neurocognitive remediation therapy to Preventive Cognitive Therapy for partially remitted depressed patients: protocol of a pragmatic multicentre randomised controlled trial.

Authors:  Claudi Bockting; Amanda M Legemaat; Johanne G J van der Stappen; Gert J Geurtsen; Maria Semkovska; Huibert Burger; Isidoor O Bergfeld; Nicoline Lous; Damiaan A J P Denys; Marlies Brouwer
Journal:  BMJ Open       Date:  2022-06-23       Impact factor: 3.006

3.  Computational Modeling of Neuropsychological Test Performance to Disentangle Impaired Cognitive Processes in Cancer Patients.

Authors:  Joost A Agelink van Rentergem; Ivar E Vermeulen; Philippe R Lee Meeuw Kjoe; Sanne B Schagen
Journal:  J Natl Cancer Inst       Date:  2021-01-04       Impact factor: 13.506

4.  The Survey for Memory, Attention, and Reaction Time (SMART): Development and Validation of a Brief Web-Based Measure of Cognition for Older Adults.

Authors:  Katherine E Dorociak; Nora Mattek; Jonathan Lee; Mira I Leese; Nicole Bouranis; Danish Imtiaz; Bridget M Doane; John P K Bernstein; Jeffrey A Kaye; Adriana M Hughes
Journal:  Gerontology       Date:  2021-04-07       Impact factor: 5.140

5.  The Wisconsin Card Sorting Test: Split-Half Reliability Estimates for a Self-Administered Computerized Variant.

Authors:  Alexander Steinke; Bruno Kopp; Florian Lange
Journal:  Brain Sci       Date:  2021-04-21

Review 6.  Cognitive Function in Older Adults With Cancer: Assessment, Management, and Research Opportunities.

Authors:  Allison Magnuson; Tim Ahles; Bihong T Chen; Jeanne Mandelblatt; Michelle C Janelsins
Journal:  J Clin Oncol       Date:  2021-05-27       Impact factor: 50.717

7.  Online Self-Administered Cognitive Testing Using the Amsterdam Cognition Scan: Establishing Psychometric Properties and Normative Data.

Authors:  Heleen Em Feenstra; Ivar E Vermeulen; Jaap Mj Murre; Sanne B Schagen
Journal:  J Med Internet Res       Date:  2018-05-30       Impact factor: 5.428

8.  Effect of physical exercise on cognitive function and brain measures after chemotherapy in patients with breast cancer (PAM study): protocol of a randomised controlled trial.

Authors:  Lenja Witlox; Sanne B Schagen; Michiel B de Ruiter; Mirjam I Geerlings; Petra H M Peeters; Emmie W Koevoets; Elsken van der Wall; Martijn Stuiver; Gabe Sonke; Miranda J Velthuis; Job A M van der Palen; Jan J Jobsen; Anne M May; E M Monninkhof
Journal:  BMJ Open       Date:  2019-06-20       Impact factor: 2.692

9.  Developing Digital Tools for Remote Clinical Research: How to Evaluate the Validity and Practicality of Active Assessments in Field Settings.

Authors:  Jennifer Ferrar; Gareth J Griffith; Caroline Skirrow; Nathan Cashdollar; Nick Taptiklis; James Dobson; Fiona Cree; Francesca K Cormack; Jennifer H Barnett; Marcus R Munafò
Journal:  J Med Internet Res       Date:  2021-06-18       Impact factor: 5.428

10.  Internet-based cognitive rehabilitation for WORking Cancer survivors (i-WORC): study protocol of a randomized controlled trial.

Authors:  Kete M Klaver; Saskia F A Duijts; Chantal A V Geusgens; Maureen J B Aarts; Rudolf W H M Ponds; Allard J van der Beek; Sanne B Schagen
Journal:  Trials       Date:  2020-07-20       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.